{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T20:46:33Z","timestamp":1772138793739,"version":"3.50.1"},"reference-count":56,"publisher":"Walter de Gruyter GmbH","issue":"3","license":[{"start":{"date-parts":[[2013,3,2]],"date-time":"2013-03-02T00:00:00Z","timestamp":1362182400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch. Immunol. Ther. Exp."],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s00005-013-0222-5","type":"journal-article","created":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T16:22:55Z","timestamp":1362154975000},"page":"245-253","source":"Crossref","is-referenced-by-count":38,"title":["The Dysfunction of NK Cells in Patients with Type 2 Diabetes and Colon Cancer"],"prefix":"10.2478","volume":"61","author":[{"given":"Pawe\u0142","family":"Pi\u0105tkiewicz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz","family":"Mi\u0142ek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u0142gorzata","family":"Bernat-Karpi\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Ohams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Czech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Ciostek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2013,3,2]]},"reference":[{"key":"222_CR1","volume-title":"Statistical methods in medical research","author":"P Armitage","year":"1971","unstructured":"Armitage P (1971) Statistical methods in medical research, 3rd edn. Blackwell Scientific Publications, Oxford","edition":"3"},{"key":"222_CR2","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/ijc.25362","volume":"128","author":"EA Atchison","year":"2011","unstructured":"Atchison EA, Gridley G, Carreon JD et al (2011) Risk of cancer in a large cohort of US veterans with diabetes. Int J Cancer 128:635\u2013643","journal-title":"Int J Cancer"},{"key":"222_CR3","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1080\/13813450802008455","volume":"114","author":"JM Berster","year":"2008","unstructured":"Berster JM, G\u00f6ke B (2008) Type 2 diabetes mellitus as risk factor for colon cancer. Arch Physiol Biochem 114:84\u201398","journal-title":"Arch Physiol Biochem"},{"key":"222_CR4","doi-asserted-by":"crossref","first-page":"8","DOI":"10.6004\/jnccn.2010.0003","volume":"8","author":"RW Burt","year":"2010","unstructured":"Burt RW, Barthel JS, Dunn KB et al (2010) NCCN clinical practice guidelines in oncology. Colorectal cancer screening. J Natl Compr Canc Netw 8:8\u201361","journal-title":"J Natl Compr Canc Netw"},{"key":"222_CR5","doi-asserted-by":"crossref","first-page":"6745","DOI":"10.1158\/0008-5472.CAN-06-4447","volume":"67","author":"M Buzzai","year":"2007","unstructured":"Buzzai M, Jones RG, Amaravadi RK et al (2007) Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth. Cancer Res 67:6745\u20136752","journal-title":"Cancer Res"},{"key":"222_CR6","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1007\/s00125-009-1440-6","volume":"52","author":"CJ Currie","year":"2009","unstructured":"Currie CJ, Poole CD, Gale EA (2009) The influence of glucose-lowering therapies on cancer risk in type 2 diabetes. Diabetologia 52:1766\u20131777","journal-title":"Diabetologia"},{"key":"222_CR7","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00005-009-0052-7","volume":"57","author":"A Czech","year":"2009","unstructured":"Czech A, Piatkiewicz P, Tato\u0144 J (2009) Cellular glucose transport and glucotransporter 4 expression as a therapeutic target: clinical and experimental studies. Arch Immunol Ther Exp 57:467\u2013473","journal-title":"Arch Immunol Ther Exp"},{"key":"222_CR8","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/j.1582-4934.2010.01083.x","volume":"15","author":"YH Feng","year":"2011","unstructured":"Feng YH, Velazquez-Torres G, Gully C et al (2011) The impact of type 2 diabetes and antidiabetic drugs on cancer cell growth. J Cell Mol Med 15:825\u2013836","journal-title":"J Cell Mol Med"},{"key":"222_CR9","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1007\/s10552-010-9555-0","volume":"21","author":"A Flood","year":"2010","unstructured":"Flood A, Strayer L, Schairer C et al (2010) Diabetes and risk of incident colorectal cancer in a prospective cohort of women. Cancer Causes Control 21:1277\u20131284","journal-title":"Cancer Causes Control"},{"key":"222_CR10","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1749-6632.2011.06285.x","volume":"1243","author":"EJ Gallagher","year":"2011","unstructured":"Gallagher EJ, LeRoith D (2011) Diabetes, cancer and metformin: connections of metabolism and cell proliferation. Ann NY Acad Sci 1243:54\u201368","journal-title":"Ann NY Acad Sci"},{"key":"222_CR11","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1158\/1078-0432.CCR-09-1805","volume":"16","author":"AM Gonzalez-Angulo","year":"2010","unstructured":"Gonzalez-Angulo AM, Meric-Bernstam F (2010) Metformin: a therapeutic opportunity in breast cancer. Clin Cancer Res 16:1695\u20131700","journal-title":"Clin Cancer Res"},{"key":"222_CR12","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0167-5699(92)90157-3","volume":"13","author":"I Hannet","year":"1992","unstructured":"Hannet I, Erkeller-Yurksel F, Deneys V et al (1992) Lymphocyte populations as a function of age. Immunol Today 13:215\u2013218","journal-title":"Immunol Today"},{"key":"222_CR13","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.coi.2010.11.008","volume":"23","author":"W Held","year":"2011","unstructured":"Held W, Kijima M, Angelov G et al (2011) The function of natural killer cells: education, reminders and some good memories. Curr Opin Immunol 23:228\u2013233","journal-title":"Curr Opin Immunol"},{"key":"222_CR14","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1634\/theoncologist.2009-0300","volume":"15","author":"K Hemminki","year":"2010","unstructured":"Hemminki K, Li X, Sundquist J, Sundquist K (2010) Risk of cancer following hospitalization for type 2 diabetes. Oncologist 15:548\u2013555","journal-title":"Oncologist"},{"key":"222_CR15","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1126\/science.7025208","volume":"214","author":"RB Herberman","year":"1981","unstructured":"Herberman RB, Ortaldo JR (1981) Natural killer cells: their role in defenses against disease. Science 214:24\u201330","journal-title":"Science"},{"key":"222_CR16","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/ijc.2910160204","volume":"16","author":"RB Herberman","year":"1975","unstructured":"Herberman RB, Nunn ME, Lavrin DH (1975a) Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. I. Distribution of reactivity and specificity. Int J Cancer 16:216\u2013229","journal-title":"Int J Cancer"},{"key":"222_CR17","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/ijc.2910160205","volume":"16","author":"RB Herberman","year":"1975","unstructured":"Herberman RB, Nunn ME, Holden HT et al (1975b) Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells. Int J Cancer 16:230\u2013239","journal-title":"Int J Cancer"},{"key":"222_CR18","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1182\/blood.V67.3.722.722","volume":"67","author":"T Hercend","year":"1986","unstructured":"Hercend T, Takvorian T, Nowill A et al (1986) Characterization of natural killer cells with antileukemia activity following allogeneic bone marrow transplantation. Blood 67:722\u2013728","journal-title":"Blood"},{"key":"222_CR19","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/978-0-387-78818-0_6","volume":"630","author":"A Hjart\u00e5ker","year":"2008","unstructured":"Hjart\u00e5ker A, Langseth H, Weiderpass E (2008) Obesity and diabetes epidemics: cancer repercussions. Adv Exp Med Biol 630:72\u201393","journal-title":"Adv Exp Med Biol"},{"key":"222_CR20","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1001\/archinte.166.17.1871","volume":"166","author":"M Inoue","year":"2006","unstructured":"Inoue M, Iwasaki M, Otani T et al (2006) Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med 166:1871\u20131877","journal-title":"Arch Intern Med"},{"key":"222_CR21","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2217\/imt.10.87","volume":"3","author":"F Iovino","year":"2011","unstructured":"Iovino F, Meraviglia S, Spina M et al (2011) Immunotherapy targeting colon cancer stem cells. Immunotherapy 3:97\u2013106","journal-title":"Immunotherapy"},{"key":"222_CR22","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.4049\/jimmunol.1000328","volume":"186","author":"AC Jaime-Ramirez","year":"2011","unstructured":"Jaime-Ramirez AC, Mundy-Bosse BL, Kondadasula S et al (2011) IL-12 enhances the antitumor actions of trastuzumab via NK cell IFN-\u03b3 production. J Immunol 186:3401\u20133409","journal-title":"J Immunol"},{"key":"222_CR23","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/ijc.22697","volume":"121","author":"M Jenab","year":"2007","unstructured":"Jenab M, Riboli E, Cleveland RJ et al (2007) Serum C-peptide, IGFBP-1 and IGFBP-2 and risk of colon and rectal cancers in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 121:368\u2013376","journal-title":"Int J Cancer"},{"key":"222_CR24","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0022-1759(95)00116-R","volume":"185","author":"S Johann","year":"1995","unstructured":"Johann S, Bl\u00fcmel G, Lipp M et al (1995) A versatile flow cytometry-based assay for the determination of short- and long-term natural killer cell activity. J Immunol Methods 185:209\u2013216","journal-title":"J Immunol Methods"},{"key":"222_CR25","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1093\/jnci\/92.19.1592","volume":"92","author":"R Kaaks","year":"2000","unstructured":"Kaaks R, Toniolo P, Akhmedkhanov A et al (2000) Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst 92:1592\u20131600","journal-title":"J Natl Cancer Inst"},{"key":"222_CR26","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.cgh.2008.12.030","volume":"7","author":"CJ Kahi","year":"2009","unstructured":"Kahi CJ, Imperiale TF, Juliar BE et al (2009) Effect of screening colonoscopy on colorectal cancer incidence. Clin Gastroenterol Hepatol 7:770\u2013775","journal-title":"Clin Gastroenterol Hepatol"},{"key":"222_CR27","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1128\/CDLI.3.3.295-300.1996","volume":"3","author":"KL Kane","year":"1996","unstructured":"Kane KL, Ashton FA, Schmitz JL et al (1996) Determination of natural killer cell function by flow cytometry. Clin Diagn Lab Immunol 3:295\u2013300","journal-title":"Clin Diagn Lab Immunol"},{"key":"222_CR28","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.4049\/jimmunol.143.10.3241","volume":"143","author":"CA Keever","year":"1989","unstructured":"Keever CA, Pekle K, Gazzola MV et al (1989) Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4. J Immunol 143:3241\u20133249","journal-title":"J Immunol"},{"key":"222_CR29","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.4049\/jimmunol.137.9.2735","volume":"137","author":"LL Lanier","year":"1986","unstructured":"Lanier LL, Phillips JH, Hackett J Jr et al (1986) Natural killer cells: definition of a cell type rather than a function. J Immunol 137:2735\u20132739","journal-title":"J Immunol"},{"key":"222_CR30","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1093\/jnci\/dji375","volume":"97","author":"SC Larsson","year":"2005","unstructured":"Larsson SC, Orsini N, Wolk A (2005) Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst 97:1679\u20131687","journal-title":"J Natl Cancer Inst"},{"issue":"Suppl 1","key":"222_CR31","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1055\/s-2008-1081488","volume":"116","author":"D LeRoith","year":"2008","unstructured":"LeRoith D, Novosyadlyy R, Gallagher EJ et al (2008) Obesity and type 2 diabetes are associated with an increased risk of developing cancer and a worse prognosis; epidemiological and mechanistic evidence. Exp Clin Endocrinol Diabetes 116(Suppl 1):S4\u2013S6","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"222_CR32","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.2337\/dc08-2175","volume":"32","author":"G Libby","year":"2009","unstructured":"Libby G, Donnelly LA, Donnan PT et al (2009) New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes. Diabetes Care 32:1620\u20131625","journal-title":"Diabetes Care"},{"key":"222_CR33","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/jnci\/djh082","volume":"96","author":"J Ma","year":"2004","unstructured":"Ma J, Giovannucci E, Pollak M et al (2004) A prospective study of plasma C-peptide and colorectal cancer risk in men. J Natl Cancer Inst 96:546\u2013553","journal-title":"J Natl Cancer Inst"},{"key":"222_CR34","first-page":"48","volume":"8","author":"G Migliorati","year":"1989","unstructured":"Migliorati G, Cannarile L, Herberman RB et al (1989) Effect of various cytokines and growth factors on the interleukin-2- dependent in vitro differentiation of natural killer cells from bone marrow. Nat Immun Cell Growth Regul 8:48\u201355","journal-title":"Nat Immun Cell Growth Regul"},{"key":"222_CR35","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/sj.emboj.7600019","volume":"23","author":"L Moretta","year":"2004","unstructured":"Moretta L, Moretta A (2004) Unravelling natural killer cell function: triggering and inhibitory human NK receptors. EMBO J 23:255\u2013259","journal-title":"EMBO J"},{"key":"222_CR36","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.imlet.2005.07.004","volume":"100","author":"L Moretta","year":"2005","unstructured":"Moretta L, Bottino C, Pende D et al (2005) Human natural killer cells: molecular mechanisms controlling NK cell activation and tumor cell lysis. Immunol Lett 100:7\u201313","journal-title":"Immunol Lett"},{"key":"222_CR37","first-page":"187","volume":"18","author":"MP Moutschen","year":"1992","unstructured":"Moutschen MP, Scheen AJ, Lefebvre PJ (1992) Impaired immune responses in diabetes mellitus: analysis of the factors and mechanisms involved. Relevance to the increased susceptibility of diabetic patients to specific infections. Diabetes Metab 18:187\u2013201","journal-title":"Diabetes Metab"},{"key":"222_CR38","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/eji.1830090204","volume":"9","author":"H Ozer","year":"1979","unstructured":"Ozer H, Strelkauskas AJ, Callery RT et al (1979) The functional dissection of human peripheral null cells with respect to antibody-dependent cytotoxicity and natural killing. Eur J Immunol 9:112\u2013118","journal-title":"Eur J Immunol"},{"key":"222_CR39","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00005-011-0119-0","volume":"59","author":"P Pi\u0105tkiewicz","year":"2011","unstructured":"Pi\u0105tkiewicz P, Czech A (2011) Glucose metabolism disorders and the risk of cancer. Arch Immunol Ther Exp 59:215\u2013230","journal-title":"Arch Immunol Ther Exp"},{"key":"222_CR40","first-page":"71","volume":"15","author":"P Pi\u0105tkiewicz","year":"2010","unstructured":"Pi\u0105tkiewicz P, Czech A, Pi\u0105tkiewicz A (2010) The pathophysiology of the NK (natural killer) cells. Med Metabol 15:71\u201376","journal-title":"Med Metabol"},{"key":"222_CR41","first-page":"11","volume-title":"Immunobiology of natural killer cells","author":"HF Pross","year":"1986","unstructured":"Pross HF (1986) The involvement of natural killer cells in human malignant disease. In: Lotzova E, Herberman RB (eds) Immunobiology of natural killer cells, vol 2. CRC, Boca Raton, p 11"},{"key":"222_CR42","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/ajg.2009.104","volume":"104","author":"DK Rex","year":"2009","unstructured":"Rex DK, Johnson DA, Anderson JC et al (2009) American Collage of Gastroenterology guidelines for colorectal cancer screening 2009. Am J Gastroenterol 104:739\u2013750","journal-title":"Am J Gastroenterol"},{"key":"222_CR43","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0065-2776(08)60845-7","volume":"42","author":"J Ritz","year":"1988","unstructured":"Ritz J, Schmidt RE, Michon J et al (1988) Characterization of functional surface structures on human natural killer cells. Adv Immunol 42:181\u2013211","journal-title":"Adv Immunol"},{"key":"222_CR44","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1182\/blood.V76.12.2421.2421","volume":"76","author":"MJ Robertson","year":"1990","unstructured":"Robertson MJ, Ritz J (1990) Biology and clinical relevance of human natural killer cells. Blood 76:2421\u20132438","journal-title":"Blood"},{"key":"222_CR45","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/284553a0","volume":"284","author":"JC Roder","year":"1980","unstructured":"Roder JC, Haliotis T, Klein M et al (1980) A new immunodeficiency disorder in humans involving NK cells. Nature 284:553\u2013555","journal-title":"Nature"},{"key":"222_CR46","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1365-2141.1986.tb02952.x","volume":"62","author":"CM Rooney","year":"1986","unstructured":"Rooney CM, Wimperis JZ, Brenner MK et al (1986) Natural killer cell activity following T-cell depleted allogeneic bone marrow transplantation. Br J Haematol 62:413\u2013420","journal-title":"Br J Haematol"},{"key":"222_CR47","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/ijc.2910090323","volume":"9","author":"EB Rosenberg","year":"1972","unstructured":"Rosenberg EB, Herberman RB, Levine PH et al (1972) Lymphocyte cytotoxicity reactions to leukemia-associated antigens in identical twins. Int J Cancer 9:648\u2013658","journal-title":"Int J Cancer"},{"key":"222_CR48","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1007\/s00262-011-1051-1","volume":"60","author":"M Sakakibara","year":"2011","unstructured":"Sakakibara M, Kanto T, Hayakawa M et al (2011) Comprehensive immunological analyses of colorectal cancer patients in the phase I\/II study of quickly matured dendritic cell vaccine pulsed with carcinoembryonic antigen peptide. Cancer Immunol Immunother 60:1565\u20131575","journal-title":"Cancer Immunol Immunother"},{"key":"222_CR49","first-page":"163","volume":"42","author":"PF Spooren","year":"1993","unstructured":"Spooren PF, Vermes I, Soons JW (1993) Similar alterations of lymphocyte subpopulations in type I and type II diabetes. Neth J Med 42:163\u2013167","journal-title":"Neth J Med"},{"key":"222_CR50","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1126\/science.6158759","volume":"210","author":"JL Sullivan","year":"1980","unstructured":"Sullivan JL, Byron KS, Brewster FE et al (1980) Deficient natural killer cell activity in X-linked lymphoproliferative syndrome. Science 210:543\u2013545","journal-title":"Science"},{"key":"222_CR51","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1084\/jem.153.3.569","volume":"153","author":"T Timonen","year":"1981","unstructured":"Timonen T, Ortaldo JR, Herberman RB (1981) Characteristics of human large granular lymphocytes and relationship to natural killer and K cells. J Exp Med 153:569\u2013582","journal-title":"J Exp Med"},{"key":"222_CR52","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0065-2776(08)60664-1","volume":"47","author":"G Trinchieri","year":"1989","unstructured":"Trinchieri G (1989) Biology of natural killer cells. Adv Immunol 47:187\u2013376","journal-title":"Adv Immunol"},{"key":"222_CR53","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1530\/EJE-12-0369","volume":"167","author":"CH Tseng","year":"2012","unstructured":"Tseng CH (2012) Diabetes, metformin use, and colon cancer: a population-based cohort study in Taiwan. Eur J Endocrinol 167:409\u2013416","journal-title":"Eur J Endocrinol"},{"key":"222_CR54","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1084\/jem.172.1.303","volume":"172","author":"MR Brink Van den","year":"1990","unstructured":"Van den Brink MR, Boggs SS, Herberman RB et al (1990) The generation of natural killer (NK) cells from NK precursor cells in rat long-term bone marrow cultures. J Exp Med 172:303\u2013313","journal-title":"J Exp Med"},{"key":"222_CR55","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1158\/1055-9965.EPI-04-0661","volume":"14","author":"EK Wei","year":"2005","unstructured":"Wei EK, Ma J, Pollak MN et al (2005) A prospective study of C-peptide, insulin-like growth factor-I, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in women. Cancer Epidemiol Biomark Prev 14:850\u20138555","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"222_CR56","doi-asserted-by":"crossref","first-page":"e21146","DOI":"10.1371\/journal.pone.0021146","volume":"6","author":"C Zheng","year":"2011","unstructured":"Zheng C, Feng J, Lu D et al (2011) A novel anti-CEACAM5 monoclonal antibody, CC4, suppresses colorectal tumor growth and enhances NK cells-mediated tumor immunity. PLoS ONE 6:e21146","journal-title":"PLoS ONE"}],"container-title":["Archivum Immunologiae et Therapiae Experimentalis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-013-0222-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00005-013-0222-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-013-0222-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T20:47:41Z","timestamp":1704228461000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00005-013-0222-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,2]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["222"],"URL":"https:\/\/doi.org\/10.1007\/s00005-013-0222-5","relation":{},"ISSN":["0004-069X","1661-4917"],"issn-type":[{"value":"0004-069X","type":"print"},{"value":"1661-4917","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,2]]}}}